Galectin-3 inhibitor GB0139 protects against acute lung injury by inhibiting neutrophil recruitment and activation

Overview of attention for article published in Frontiers in Pharmacology, August 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

twitter: 3 X users

Citations

dimensions_citation: 20 Dimensions

Readers on

mendeley: 13 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 11,827 followers.

RT @Paul_Briley: @dgurdasani1 @TristanVeness I've switched from Tollovid to a Galectin-3 inhibitor instead as Omicron has been shown to eva…

06 Jun 2023

Reply Repost Favourite

@dgurdasani1 @TristanVeness I've switched from Tollovid to a Galectin-3 inhibitor instead as Omicron has been shown to evade 3CL protease inhibitors. I'm using Modified Citrus Pectin. https://t.co/gkbJKQt3Og https://t.co/AZK2ReCp3a https://t.co/dzNuXpg

02 Jun 2023

Reply Repost Favourite

New Research: Galectin-3 inhibitor GB0139 protects against acute lung injury by inhibiting neutrophil recruitment and activation https://t.co/kTlNqTLpPp #pharmacology

08 Aug 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.